![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Democrats Propose Bill to Give Medicare More Price Negotiation Power
Democrats Propose Bill to Give Medicare More Price Negotiation Power
![](https://www.fdanews.com/ext/resources/test/Drug-Images4/MedicareonBlackBoard.gif?t=1479253274&width=430)
July 30, 2018
Rep. Lloyd Doggett (D-Texas) and almost 70 Democratic cosponsors introduced legislation that would give Medicare expanded authority to use its market power to negotiate lower drug prices.
Doggett described the bill as “[calling] the President’s bluff on his drug pricing promises.”
The Medicare Negotiation and Competitive Licensing Act would authorize Medicare to negotiate drug prices in a way similar to the Veteran’s Administration.
“It defies logic that the federal government is not using its enormous purchasing power to get a better deal for seniors on prescription drugs,” said Rep. Peter Welch (D-Ver.).
Upcoming Events
-
21Oct